.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cerilliant
Citi
Colorcon
Chinese Patent Office
Fish and Richardson
UBS
Dow
Teva
Moodys

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205087

« Back to Dashboard

NDA 205087 describes CYPROHEPTADINE HYDROCHLORIDE, which is a drug marketed by Actavis Mid Atlantic, Bio-pharm Inc, Halsey, Lyne, Morton Grove, Naska, Pharm Assoc, Silarx Pharms Inc, Ailex Pharms Llc, Am Therap, Apex Pharms Inc, Appco Pharma Llc, Ascot, Chartwell Rx, Duramed Pharms Barr, Impax Labs Inc, Ingenus Pharms Nj, Ivax Sub Teva Pharms, Kv Pharm, Md Pharm, Mylan, Par Pharm, Pioneer Pharms, Pliva, Sandoz, Santos Biotech, Superpharm, Vitarine, Watson Labs, and Zydus Pharms Usa Inc, and is included in thirty-three NDAs. It is available from twenty-four suppliers. Additional details are available on the CYPROHEPTADINE HYDROCHLORIDE profile page.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.

Summary for 205087

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 205087

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 205087 ANDA Ingenus Pharmaceuticals LLC 50742-190 50742-190-01 100 TABLET in 1 BOTTLE, PLASTIC (50742-190-01)
CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 205087 ANDA Ingenus Pharmaceuticals LLC 50742-190 50742-190-10 1000 TABLET in 1 BOTTLE, PLASTIC (50742-190-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Sep 23, 2015TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Cerilliant
Argus Health
QuintilesIMS
Cantor Fitzgerald
Citi
Mallinckrodt
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot